Reference
- Kanno K, et al. Cutaneous adverse reaction of mogamulizumab, an anti-CC chemokine receptor 4 monoclonal antibody: Shared histopathological features with thymoma-associated multi-organ autoimmunity. Journal of Dermatology 44: e117-e118, No. 6, Jun 2017. Available from: URL: http://doi.org/10.1111/1346-8138.13738 - JapanCrossRefPubMedGoogle Scholar
Copyright information
© Springer International Publishing AG 2017